AI Terminal
Dr. Martens PLC
Director's Dealing • Sep 24, 2024
5055_dirs_2024-09-24_b857ae94-bf3e-4888-8e13-8833667e29fc.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 4919F
Dr. Martens PLC
24 September 2024
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 24 September 2024 of the following transaction in the Company's Ordinary 1p shares (the 'shares') undertaken by a director / person discharging managerial responsibility ('PDMRs'):
-
In order to effect a 'Bed and ISA' transaction, Robyn Perriss, Independent Non-Executive Director, sold 89,054 ordinary shares of 1 pence each in the Company ('Ordinary Shares') at a price of £0.515 per Ordinary Share and then repurchased 89,054 Ordinary Shares into her ISA at a price of £0.5155 per Ordinary Share. Following these transactions, Robyn's overall beneficial interest in the Company's Ordinary Shares remains unchanged at 99,328 Ordinary Shares.
The relevant notifications, set out below, are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Robyn Perriss
2
Reason for the notification
a)
Position/status
PDMR (Non-Executive Director)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
Sale of Ordinary Shares in order to effect a
Bed & Isa transaction
c)
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| £0.515 | 89,054 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
Single transaction
e)
Date of the transaction
24 September 2024
f)
Place of the transaction
London Stock Exchange (XLON)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Robyn Perriss
2
Reason for the notification
a)
Position/status
PDMR (Non-Executive Director)
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Dr. Martens plc
b)
LEI
213800QPT8YM6NQZPH28
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24
b)
Nature of the transaction
Purchase of Ordinary Shares to complete a
Bed & Isa transaction
c)
Price(s) and volume(s)
| Price(s) | Volume(s) | |
| £0.5155 | 89,054 |
d)
Aggregated information
| - | Aggregated volume |
| - | Price |
Single transaction
e)
Date of the transaction
24 September 2024
f)
Place of the transaction
London Stock Exchange (XLON)
For further information please contact:
Paul Rolling
Assistant Company Secretary
+4475 8424 3562
Bethany Barnes
Director of Investor Relations
+4478 2518 7465
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUSVVRSRUKUAR